Gastrointestinal Cancer News

Firefighters who take skin decontamination measures immediately after fighting fires may reduce skin absorption of potentially cancer-causing compounds, according to study results.

The Colorectal Cancer Alliance, a national nonprofit, has awarded a $125,000 grant to study a possible link between colon microbiota and colorectal cancer, according to a press release.

Child-Pugh B and C, and elevated alpha-fetoprotein, at diagnosis of hepatocellular carcinoma corresponded with a diagnosis outside Milan criteria and surveillance failure during a surveillance program of patients with cirrhosis.

Five-year survival for the most common 18 cancers remained highest globally for the United States, Canada, Australia and New Zealand, followed by Finland, Iceland, Norway and Sweden, according to data through 2014 from CONCORD-3.

Patients with esophageal cancer who undergo esophagectomy are more likely to survive long term than patients who are recommended surgery but refuse, according to research presented at the 54th Annual Meeting of The Society of Thoracic Surgeons.

Bariatric surgery appeared associated with reduced risk for certain obesity-associated malignancies, according to results of a retrospective cohort study.

The FDA approved lutetium Lu 177 dotatate for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors, including foregut, midgut and hindgut tumors.

Researchers at Johns Hopkins Kimmel Cancer Center developed a test that they say identifies several types of cancers in early stages.

The FDA granted orphan drug designation to BPM31510 for the treatment of pancreatic cancer, according to the agent’s manufacturer.

Pembrolizumab treatment led to durable OS and PFS among patients with advanced hepatocellular carcinoma who previously progressed on sorafenib, according to results of the phase 2 KEYNOTE-224 clinical trial presented at the Gastrointestinal Cancers Symposium.